Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Erratum: "Environmental, Dietary, Maternal, and Fetal Predictors of Bulky DNA Adducts in Cord Blood: A European Mother-Child Study (NewGeneris)".

Pedersen M, Mendez MA, Schoket B, Godschalk RW, Espinosa A, Landström A, Villanueva CM, Merlo DF, Fthenou E, Gracia-Lavedan E, van Schooten FJ, Hoek G, Brunborg G, Meltzer HM, Alexander J, Nielsen JK, Sunyer J, Wright J, Kovács K, de Hoogh K, Gutzkow KB, Hardie LJ, Chatzi L, Knudsen LE, Anna L, Ketzel M, Haugen M, Botsivali M, Nieuwenhuijsen MJ, Cirach M, Toledano MB, Smith RB, Fleming S, Agramunt S, Kyrtopoulos SA, Lukács V, Kleinjans JC, Segerbäck D, Kogevinas M.

Environ Health Perspect. 2016 Jan;124(1):A12. doi: 10.1289/ehp.124-A12. No abstract available.

2.

Environmental, dietary, maternal, and fetal predictors of bulky DNA adducts in cord blood: a European mother-child study (NewGeneris).

Pedersen M, Mendez MA, Schoket B, Godschalk RW, Espinosa A, Landström A, Villanueva CM, Merlo DF, Fthenou E, Gracia-Lavedan E, van Schooten FJ, Hoek G, Brunborg G, Meltzer HM, Alexander J, Nielsen JK, Sunyer J, Wright J, Kovács K, de Hoogh K, Gutzkow KB, Hardie LJ, Chatzi L, Knudsen LE, Anna L, Ketzel M, Haugen M, Botsivali M, Nieuwenhuijsen MJ, Cirach M, Toledano MB, Smith RB, Fleming S, Agramunt S, Kyrtopoulos SA, Lukács V, Kleinjans JC, Segerbäck D, Kogevinas M.

Environ Health Perspect. 2015 Apr;123(4):374-80. doi: 10.1289/ehp.1408613. Epub 2015 Jan 27. Erratum in: Environ Health Perspect. 2016 Jan;124(1):A12.

3.

Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort.

Merlo DF, Agramunt S, Anna L, Besselink H, Botsivali M, Brady NJ, Ceppi M, Chatzi L, Chen B, Decordier I, Farmer PB, Fleming S, Fontana V, Försti A, Fthenou E, Gallo F, Georgiadis P, Gmuender H, Godschalk RW, Granum B, Hardie LJ, Hemminki K, Hochstenbach K, Knudsen LE, Kogevinas M, Kovács K, Kyrtopoulos SA, Løvik M, Nielsen JK, Nygaard UC, Pedersen M, Rydberg P, Schoket B, Segerbäck D, Singh R, Sunyer J, Törnqvist M, van Loveren H, van Schooten FJ, Vande Loock K, von Stedingk H, Wright J, Kleinjans JC, Kirsch-Volders M, van Delft JH; NewGeneris Consortium.

Environ Health Perspect. 2014 Feb;122(2):193-200. doi: 10.1289/ehp.1206324. Epub 2013 Nov 19.

4.

Bulky dna adducts in cord blood, maternal fruit-and-vegetable consumption, and birth weight in a European mother-child study (NewGeneris).

Pedersen M, Schoket B, Godschalk RW, Wright J, von Stedingk H, Törnqvist M, Sunyer J, Nielsen JK, Merlo DF, Mendez MA, Meltzer HM, Lukács V, Landström A, Kyrtopoulos SA, Kovács K, Knudsen LE, Haugen M, Hardie LJ, Gützkow KB, Fleming S, Fthenou E, Farmer PB, Espinosa A, Chatzi L, Brunborg G, Brady NJ, Botsivali M, Arab K, Anna L, Alexander J, Agramunt S, Kleinjans JC, Segerbäck D, Kogevinas M.

Environ Health Perspect. 2013 Oct;121(10):1200-6. doi: 10.1289/ehp.1206333. Epub 2013 Jul 23.

5.

Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo[a]pyrene and other polycyclic aromatic hydrocarbons.

Georgiadis P, Kovács K, Kaila S, Makedonopoulou P, Anna L, Poirier MC, Knudsen LE, Schoket B, Kyrtopoulos SA.

Mutagenesis. 2012 Sep;27(5):589-97. doi: 10.1093/mutage/ges024. Epub 2012 May 18.

6.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P; STROBE Statement.

PLoS Med. 2011 Oct;8(10):e1001117. doi: 10.1371/journal.pmed.1001117. Epub 2011 Oct 25. No abstract available.

7.

STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Eur J Epidemiol. 2011 Oct;26(10):797-810. doi: 10.1007/s10654-011-9622-1. Epub 2011 Oct 29. Erratum in: Eur J Epidemiol. 2012 Feb;27(2):151.

PMID:
22037796
8.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology STROBE-ME: an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

J Clin Epidemiol. 2011 Dec;64(12):1350-63. doi: 10.1016/j.jclinepi.2011.07.010. Erratum in: J Clin Epidemiol. 2012 Jul;65(7):813.

PMID:
22030070
9.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Prev Med. 2011 Dec;53(6):377-87. doi: 10.1016/j.ypmed.2011.08.007. Epub 2011 Oct 24. Erratum in: Prev Med. 2012 May;54(5):367.

PMID:
22029945
10.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Mutagenesis. 2012 Jan;27(1):17-29. doi: 10.1093/mutage/ger039. Epub 2011 Oct 25. Erratum in: Mutagenesis. 2012 May;27(3):383.

PMID:
22027842
11.

STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

J Epidemiol Community Health. 2012 Sep;66(9):844-54. doi: 10.1136/jech-2011-200318. Epub 2011 Oct 24.

PMID:
22025194
12.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Eur J Clin Invest. 2012 Jan;42(1):1-16. doi: 10.1111/j.1365-2362.2011.02561.x. Epub 2011 Oct 25. Erratum in: Eur J Clin Invest. 2012 Apr;42(4):462.

13.

Smoking-related O4-ethylthymidine formation in human lung tissue and comparisons with bulky DNA adducts.

Anna L, Kovács K, Gyorffy E, Schoket B, Nair J.

Mutagenesis. 2011 Jul;26(4):523-7. doi: 10.1093/mutage/ger011. Epub 2011 Mar 30.

PMID:
21454326
14.

Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.

Kovács K, Anna L, Rudnai P, Schoket B.

Mutat Res. 2011 Mar 18;721(1):95-100. doi: 10.1016/j.mrgentox.2010.12.012. Epub 2011 Jan 13.

PMID:
21237286
15.

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

Komlósi V, Hitre E, Pap E, Adleff V, Réti A, Székely E, Bíró A, Rudnai P, Schoket B, Müller J, Tóth B, Ottó S, Kásler M, Kralovánszky J, Budai B.

BMC Cancer. 2010 Oct 4;10:525. doi: 10.1186/1471-2407-10-525.

16.

Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.

Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B.

Mutagenesis. 2009 Nov;24(6):475-80. doi: 10.1093/mutage/gep031. Epub 2009 Jul 30.

PMID:
19643813
17.

Validation of biomarkers for the study of environmental carcinogens: a review.

Gallo V, Khan A, Gonzales C, Phillips DH, Schoket B, Györffy E, Anna L, Kovács K, Møller P, Loft S, Kyrtopoulos S, Matullo G, Vineis P.

Biomarkers. 2008 Aug;13(5):505-34. Review.

PMID:
18979642
18.

Glutathione S-transferase enzyme polymorphisms in a Hungarian myelodysplasia study population.

Várkonyi J, Szakály D, Jánoskúti L, Hosszúfalusi N, Pánczél P, Karádi I, Schoket B.

Pathol Oncol Res. 2008 Dec;14(4):429-33. doi: 10.1007/s12253-008-9008-1. Epub 2008 May 21.

19.

Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.

Gyorffy E, Anna L, Kovács K, Rudnai P, Schoket B.

Mutagenesis. 2008 Jan;23(1):1-18. Epub 2007 Nov 7. Review.

PMID:
17989146
20.

Biomarkers and molecular epidemiology--present state and future trends: concluding remarks.

Kyrtopoulos SA, Sarrif A, Elliott BM, Schoket B, Demopoulos NA.

Mutat Res. 2006 Aug 30;600(1-2):77-8. Epub 2006 Jun 27. No abstract available.

PMID:
16806291
21.

High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.

Beland FA, Churchwell MI, Von Tungeln LS, Chen S, Fu PP, Culp SJ, Schoket B, Gyorffy E, Minárovits J, Poirier MC, Bowman ED, Weston A, Doerge DR.

Chem Res Toxicol. 2005 Aug;18(8):1306-15.

PMID:
16097804
22.

Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.

Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, Leoni VP, Le Marchand L, London SJ, Neri M, Povey AC, Rannug A, Reszka E, Ryberg D, Risch A, Romkes M, Ruano-Ravina A, Schoket B, Spinola M, Sugimura H, Wu X, Taioli E.

Mutat Res. 2005 Dec 30;592(1-2):45-57. Epub 2005 Jul 11.

PMID:
16009381
23.

CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.

Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E.

Biomarkers. 2004 May-Jun;9(3):298-305.

PMID:
15764294
24.

[The role of DNA adducts in smoking-related carcinogenesis].

Schoket B.

Magy Onkol. 2004;48(3):201-5. Epub 2004 Nov 1. Review. Hungarian.

25.

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.

Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Coutelle C, Daly AK, Muzi G, Dolzan V, Duzhak TG, Farker K, Golka K, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Katoh T, Kihara M, Ono-Kihara M, Kim H, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, London S, Manni JJ, Maugard CM, Morgan GJ, Morita S, Nazar-Stewart V, Kristensen VN, Oda Y, Parl FF, Peters WH, Rannug A, Rebbeck T, Pinto LF, Risch A, Romkes M, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnett D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Zheng W, Pedotti P, Taioli E.

Int J Cancer. 2004 Jun 10;110(2):266-70.

26.

DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.

Gyorffy E, Anna L, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Poirier MC, Schoket B.

Carcinogenesis. 2004 Jul;25(7):1201-9. Epub 2004 Mar 4.

PMID:
15001535
27.

CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.

Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E.

Carcinogenesis. 2003 May;24(5):875-82.

PMID:
12771031
28.

Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years.

Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Kalina I, Kremers P, Le Marchand L, London S, Rannug A, Romkes M, Schoket B, Seidegard J, Strange RC, Stucker I, To-Figueras J, Garte S.

Int J Epidemiol. 2003 Feb;32(1):60-3.

PMID:
12690010
29.

CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.

Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L, Taioli E.

Int J Cancer. 2003 May 1;104(5):650-7.

30.

Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring.

Divi RL, Beland FA, Fu PP, Von Tungeln LS, Schoket B, Camara JE, Ghei M, Rothman N, Sinha R, Poirier MC.

Carcinogenesis. 2002 Dec;23(12):2043-9.

PMID:
12507927
31.

Metabolic gene polymorphism frequencies in control populations.

Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stücker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E.

Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1239-48.

32.

Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure.

Schoket B, Papp G, Lévay K, Mracková G, Kadlubar FF, Vincze I.

Mutat Res. 2001 Oct 1;482(1-2):57-69.

PMID:
11535249
33.

Biomonitoring of human genotoxicity induced by complex occupational exposures.

Schoket B, Poirier MC, Mayer G, Török G, Kolozsi-Ringelhann A, Bognár G, Bigbee WL, Vincze I.

Mutat Res. 1999 Sep 30;445(2):193-203.

PMID:
10575430
34.

Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases.

Ozawa S, Schoket B, McDaniel LP, Tang YM, Ambrosone CB, Kostic S, Vincze I, Kadlubar FF.

Carcinogenesis. 1999 Jun;20(6):991-5.

PMID:
10357778
35.
36.

Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.

Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B, Marques MM.

Chem Res Toxicol. 1999 Jan;12(1):68-77.

PMID:
9894020
37.

Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients.

Schoket B, Phillips DH, Kostic S, Vincze I.

Carcinogenesis. 1998 May;19(5):841-6.

PMID:
9635872
38.

Biomonitoring of United States Army soldiers serving in Kuwait in 1991.

Poirier MC, Weston A, Schoket B, Shamkhani H, Pan CF, McDiarmid MA, Scott BG, Deeter DP, Heller JM, Jacobson-Kram D, Rothman N.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):545-51.

39.
40.

Detection of polycyclic aromatic hydrocarbon exposure damage using different methods in laboratory animals.

Winker N, Weniger P, Klein W, Ott E, Kocsis F, Schoket B, Körpert K.

J Appl Toxicol. 1995 Jan-Feb;15(1):59-62.

PMID:
7745228
41.

Smoking-related increase in O6-alkylguanine-DNA alkyltransferase activity in human lung tissue.

Drin I, Schoket B, Kostic S, Vincze I.

Carcinogenesis. 1994 Aug;15(8):1535-9.

PMID:
8055630
42.

Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA).

Schoket B, Doty WA, Vincze I, Strickland PT, Ferri GM, Assennato G, Poirier MC.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):349-53.

43.
44.

Biomarkers of carcinogen exposure and cancer risk in a coke plant.

Assennato G, Ferri GM, Tockman MS, Poirier MC, Schoket B, Porro A, Corrado V, Strickland PT.

Environ Health Perspect. 1993 Mar;99:237-9.

45.

Smoking-related DNA adducts: 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA.

Mustonen R, Schoket B, Hemminki K.

Carcinogenesis. 1993 Jan;14(1):151-4.

PMID:
8425264
46.

Monitoring occupational exposure to carcinogens.

Schoket B.

IARC Sci Publ. 1993;(124):341-7. Review.

PMID:
8225504
47.

Determination of smoking-related DNA adducts in lung-cancer and non-cancer patients.

Schoket B, Kostic S, Vincze I.

IARC Sci Publ. 1993;(124):315-9.

PMID:
8225500
48.
49.

Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells.

Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I.

Int J Cancer. 1990 Oct 15;46(4):569-75.

PMID:
2210880
50.

Supplemental Content

Loading ...
Support Center